Updated Jul 16, 2026
WAGNER CHARLES F JR has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $7.94M.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-02-26 | VRTX | VERTEX PHARMACEUTICALS INC / MA | F — Tax withholding / forfeiture | 1.7K | $485.11 | $846K |
| 2026-02-19 | VRTX | VERTEX PHARMACEUTICALS INC / MA | F — Tax withholding / forfeiture | 2.3K | $483.75 | $1.11M |
| 2026-02-19 | VRTX | VERTEX PHARMACEUTICALS INC / MA | A — Grant or award | 7.4K | $0.00 | |
| 2026-02-18 | VRTX | VERTEX PHARMACEUTICALS INC / MA | F — Tax withholding / forfeiture | 4.6K | $487.76 | $2.23M |
| 2026-02-12 | VRTX | VERTEX PHARMACEUTICALS INC / MA | F — Tax withholding / forfeiture | 3.0K | $468.41 | $1.43M |
| 2026-01-26 | VRTX | VERTEX PHARMACEUTICALS INC / MA | A — Grant or award | 4.2K | $0.00 | |
| 2026-01-26 | VRTX | VERTEX PHARMACEUTICALS INC / MA | A — Grant or award | 9.4K | $0.00 | |
| 2025-12-05 | VRTX | VERTEX PHARMACEUTICALS INC / MA | S — Open-market sale [10b5-1] | 7.0K | $461.00 | $3.23M |
| 2025-12-05 | VRTX | VERTEX PHARMACEUTICALS INC / MA | S — Open-market sale [10b5-1] | 7.0K | $451.00 | $3.16M |
| 2024-11-13 | VRTX | VERTEX PHARMACEUTICALS INC / MA | S — Open-market sale [10b5-1] | 3.0K | $518.27 | $1.55M |
WAGNER CHARLES F JR is a corporate insider — currently tracked as Insider of TJX COMPANIES INC /DE/ (TJX). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 3 open-market sales ($7.94M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live WAGNER CHARLES F JR profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.